270 related articles for article (PubMed ID: 25648306)
1. Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis.
Dumnicka P; Zylka A; Kusnierz-Cabala B; Gurda-Duda A; Kuzniewski M; Drozdz R; Kulig J
Folia Med Cracov; 2014; 54(2):17-26. PubMed ID: 25648306
[TBL] [Abstract][Full Text] [Related]
2. Determination of hepatocyte growth factor at early phase of acute pancreatitis.
Sporek M; Kolber W; Kusnierz-Cabala B; Dumnicka P; Gurda-Duda A; Kuzniewski M; Solnica B; Kulig J
Folia Med Cracov; 2013; 53(1):87-95. PubMed ID: 24858334
[TBL] [Abstract][Full Text] [Related]
3. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort.
Audo R; Daien C; Papon L; Lukas C; Vittecoq O; Hahne M; Combe B; Morel J
Arthritis Res Ther; 2015 Jul; 17(1):193. PubMed ID: 26220665
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis.
Hofbauer LC; Schoppet M; Christ M; Teichmann J; Lange U
Rheumatology (Oxford); 2006 Oct; 45(10):1218-22. PubMed ID: 16574701
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin and osteoprotegerin/TRAIL ratio are associated with cardiovascular dysfunction and mortality among patients with renal failure.
Kuźniewski M; Fedak D; Dumnicka P; Stępień E; Kuśnierz-Cabala B; Cwynar M; Sułowicz W
Adv Med Sci; 2016 Sep; 61(2):269-275. PubMed ID: 27128817
[TBL] [Abstract][Full Text] [Related]
7. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients.
Davenport C; Kenny H; Ashley DT; O'Sullivan EP; Smith D; O'Gorman DJ
Eur J Clin Invest; 2012 Nov; 42(11):1173-9. PubMed ID: 22803952
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions.
Karatolios K; Pankuweit S; Goettsch C; Hofbauer LC; Timmesfeld N; Al-Fakhri N; Maisch B; Schoppet M
Clin Biochem; 2012 Feb; 45(3):237-42. PubMed ID: 22202560
[TBL] [Abstract][Full Text] [Related]
9. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke.
Pan X; Pang M; Ma A; Wang K; Zhang Z; Zhong Q; Yang S
PLoS One; 2015; 10(9):e0136414. PubMed ID: 26334877
[TBL] [Abstract][Full Text] [Related]
10. An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction.
Secchiero P; Corallini F; Beltrami AP; Ceconi C; Bonasia V; Di Chiara A; Ferrari R; Zauli G
Atherosclerosis; 2010 May; 210(1):274-7. PubMed ID: 20015493
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies.
Castellino G; Corallini F; Trotta F; Secchiero P
Lupus; 2007; 16(7):479-82. PubMed ID: 17670845
[TBL] [Abstract][Full Text] [Related]
12. Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease.
Shaker OG; El-Shehaby A; Nabih M
Angiology; 2010 Nov; 61(8):756-62. PubMed ID: 20498140
[TBL] [Abstract][Full Text] [Related]
13. Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs.
Secchiero P; Corallini F; Castellino G; Bortoluzzi A; Caruso L; Bugatti S; Bosco R; Montecucco M; Trotta F
J Rheumatol; 2010 Jul; 37(7):1461-6. PubMed ID: 20472926
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic importance of pentraxins at the early phase of acute pancreatitis].
Meryk P; Dumnicka P; Kuśnierz-Cabala B; Kuźniewski M; Kapusta M; Gurda-Duda A; Goebels M; Pawlica-Gosiewska D; Kulig J
Przegl Lek; 2014; 71(6):309-13. PubMed ID: 25344970
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation.
Rewiuk K; Grodzicki T
Biomed Res Int; 2015; 2015():259843. PubMed ID: 26504794
[TBL] [Abstract][Full Text] [Related]
16. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis.
Dessein PH; Lopez-Mejias R; Ubilla B; Genre F; Corrales A; Hernandez JL; Ferraz-Amaro I; Tsang L; Pina T; Llorca J; Blanco R; Gonzalez-Juanatey C; Gonzalez-Gay MA
Clin Exp Rheumatol; 2015; 33(4):491-7. PubMed ID: 25962765
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
18. Is there any role for tumour necrosis factor related apoptosis inducing ligand-osteoprotegerin (TRAIL-OPG) interaction in rheumatoid arthritis?
Castellino G; Corallini F; Trotta F; Secchiero P
Ann Rheum Dis; 2008 Aug; 67(8):1196-7. PubMed ID: 18621972
[No Abstract] [Full Text] [Related]
19. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells.
Miyashita T; Kawakami A; Nakashima T; Yamasaki S; Tamai M; Tanaka F; Kamachi M; Ida H; Migita K; Origuchi T; Nakao K; Eguchi K
Clin Exp Immunol; 2004 Aug; 137(2):430-6. PubMed ID: 15270863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
